GO:0043529 GET complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043529 GET complex is a conserved endoplasmic reticulum (ER) protein complex that mediates insertion of tail-anchored (TA) proteins into the ER membrane.
• The complex is defined by the QuickGO definition and includes yeast Get1p, Get2p, and Get3p; metazoan orthologs include WRB (Get1), CAML (Get2), and TRC40/ASNA1 (Get3).
• TA proteins are a large class of membrane proteins involved in vesicle trafficking, apoptosis, and organelle identity; their correct ER insertion is essential for cellular homeostasis.
• The GET complex is a validated drug target in protozoan parasites, where it is essential for viability and is being explored for antiparasitic development.
• Experimental models for studying the GET complex include CRISPR knockout, point mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening and bioinformatics.
• The GET complex is a model system for understanding membrane protein biogenesis and is linked to human diseases such as cancer and neurodegeneration through TA protein dysfunction.
Description
The GET complex (guided entry of tail-anchored proteins) is a conserved endoplasmic reticulum (ER) protein-containing complex that mediates the post-translational insertion of tail-anchored (TA) proteins into the ER membrane. TA proteins are characterized by a single C-terminal transmembrane domain and play essential roles in vesicle trafficking, apoptosis, and organelle identity. The GET complex is defined by the Gene Ontology term GO:0043529 and is conserved across eukaryotes, with yeast Get1p, Get2p, and Get3p as core components. In metazoans, the complex comprises WRB (Get1), CAML (Get2), and TRC40/ASNA1 (Get3). Researchers study the GET complex to understand how cells maintain membrane protein homeostasis and to identify therapeutic targets for diseases linked to TA protein mislocalization. The complex is also a validated target in protozoan parasites, where its function is essential for viability. This article provides a research-grade overview of the GET complex, including its structure, mechanism, regulation, disease relevance, and experimental models, with a focus on CRISPR-based approaches for functional interrogation.
GET complex At A Glance
| GO ID | GO:0043529 |
|---|---|
| GO term | GET complex |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Mediates insertion of tail-anchored proteins into the ER membrane |
| Conservation | Conserved in eukaryotes |
| Yeast components | Get1p, Get2p, Get3p |
| Metazoan orthologs | WRB (Get1), CAML (Get2), TRC40/ASNA1 (Get3) |
| Subcellular location | Endoplasmic reticulum membrane |
What Is GO:0043529?
The GET complex is an endoplasmic reticulum protein-containing complex that is conserved in eukaryotes and that mediates the insertion of tail-anchored proteins into the ER membrane. In yeast, it includes Get1p, Get2p, and Get3p proteins. The complex is annotated under GO:0043529 in the cellular_component ontology.
Why Is GET complex Important in Cell Biology?
The GET complex is essential for the biogenesis of tail-anchored proteins, a diverse class of membrane proteins that regulate vesicle trafficking, apoptosis, and organelle dynamics. Dysfunction of the GET complex leads to mislocalization of TA proteins, which is associated with human diseases including cancer and neurodegeneration. Moreover, the GET complex is a validated drug target in protozoan parasites, highlighting its potential for therapeutic intervention. Understanding its structure, mechanism, and regulation is therefore critical for both basic cell biology and translational research.
• Essential for post-translational insertion of tail-anchored proteins into the ER membrane.
• TA proteins include SNAREs, Bcl-2 family members, and cytochrome b5, which are critical for vesicle trafficking and apoptosis.
• The GET complex is conserved from yeast to humans, making it a tractable model for mechanistic studies.
• Mutations in GET complex components are linked to cancer and neurodegenerative disorders.
• The complex is a validated target in protozoan parasites, offering a route to new antiparasitic drugs.
• CRISPR-based knockout, point mutation, and knock-in models enable precise functional interrogation of GET complex genes.
• High-throughput screening and bioinformatics can identify novel regulators and interactors of the GET complex.
• The GET complex is a paradigm for understanding membrane protein biogenesis and ER homeostasis.
Core Biology of the GET complex
What Happens During GET complex?
In simple terms: The GET complex helps newly made tail-anchored proteins find their way into the ER membrane.
The GET complex mediates the post-translational insertion of tail-anchored proteins into the ER membrane. The process begins with the recognition of the TA protein by Get3 (TRC40/ASNA1), which binds the hydrophobic transmembrane domain and shields it from the cytosol. Get3 then delivers the TA protein to the ER membrane by interacting with the Get1-Get2 receptor complex (WRB-CAML in metazoans). The TA protein is subsequently released and inserted into the lipid bilayer, while Get3 is recycled.
Structure and Composition of GET complex
In simple terms: The GET complex is made of three main proteins that work together like a delivery truck, a dock, and a receiver.
In yeast, the GET complex comprises Get1p, Get2p, and Get3p. Get3 is a cytosolic ATPase that binds TA proteins, while Get1 and Get2 are ER membrane proteins that form the receptor for Get3. In metazoans, the orthologs are WRB (Get1), CAML (Get2), and TRC40/ASNA1 (Get3). The complex is anchored in the ER membrane and is conserved across eukaryotes.
Molecular Mechanism of GET complex
In simple terms: The GET complex uses energy from ATP to catch, carry, and release tail-anchored proteins into the ER membrane.
Get3 is an ATPase that cycles between ATP-bound and ADP-bound states to capture and release TA proteins. The ATP-bound form of Get3 binds the TA protein with high affinity, and upon interaction with Get1-Get2, ATP hydrolysis triggers conformational changes that release the TA protein into the membrane. The Get1-Get2 receptor complex coordinates this release and ensures insertion into the ER bilayer. This mechanism is conserved in eukaryotes.
Regulation of GET complex
In simple terms: The GET complex is controlled by cellular energy levels and stress signals.
The GET complex is regulated by the availability of ATP and by cellular stress pathways that modulate ER homeostasis. The ATPase cycle of Get3 is central to its function, and mutations that affect ATP binding or hydrolysis impair TA protein insertion. Additionally, the expression of GET complex components can be regulated at the transcriptional level in response to ER stress.
Key Genes Involved in GO:0043529 GET complex
The following genes and proteins are core components or key regulators of the GET complex, based on the QuickGO definition and published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GET1 (WRB) | ER membrane receptor for Get3; forms complex with Get2 | Knockout causes TA protein mislocalization; linked to cancer |
| GET2 (CAML) | ER membrane receptor for Get3; forms complex with Get1 | Essential for TA protein insertion; potential drug target |
| GET3 (TRC40/ASNA1) | Cytosolic ATPase that binds and delivers TA proteins | Knockout is lethal in yeast; mutations affect ATPase cycle |
| GET4 | Co-chaperone that facilitates TA protein transfer to Get3 | Regulates efficiency of TA protein capture |
| GET5 | Co-chaperone that facilitates TA protein transfer to Get3 | Regulates efficiency of TA protein capture |
| SGT2 | Co-chaperone that binds TA proteins and delivers them to Get4/Get5 | Knockdown impairs TA protein biogenesis |
| HSP70 (SSA1) | Chaperone that maintains TA proteins in a insertion-competent state | Chemical inhibition affects GET complex function |
| HSP40 (YDJ1) | Co-chaperone that works with Hsp70 | Modulates TA protein targeting |
| SEC61 | ER translocon; not part of GET complex but involved in membrane insertion | Comparative studies of insertion pathways |
| BAG6 | Metazoan co-chaperone involved in TA protein targeting | Knockdown affects TA protein stability |
| UBC4 | Ubiquitin-conjugating enzyme that regulates Get3 | Affects Get3 turnover |
| RAD23 | Ubiquitin receptor involved in ER-associated degradation | Cross-talk with GET complex |
| CDC48 (VCP/p97) | AAA-ATPase involved in extraction of mislocalized proteins | Inhibitors affect GET complex quality control |
| ASNA1 (TRC40) | Metazoan ortholog of Get3 | Knockout causes embryonic lethality in mice |
| WRB | Metazoan ortholog of Get1 | Mutations linked to cancer and developmental disorders |
| CAML | Metazoan ortholog of Get2 | Regulates TA protein insertion and immune signaling |
| GET3 (yeast) | Model ATPase for mechanistic studies | Extensively used in structural biology |
How Is GET complex Regulated?
The GET complex is regulated by the ATPase cycle of Get3, which is controlled by ATP binding and hydrolysis. Cellular stress pathways, including the unfolded protein response, can modulate the expression of GET complex components to maintain ER homeostasis. Additionally, post-translational modifications such as ubiquitination regulate Get3 stability and function.
GET complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WRB | Cancer, developmental disorders | CRISPR knockout in cancer cell lines |
| ASNA1 (TRC40) | Neurodegeneration, embryonic lethality | Conditional knockout in mouse neurons |
| CAML | Immune signaling, cancer | Knock-in of patient mutations |
| GET3 | Parasitic infections | CRISPR knockout in Plasmodium |
| GET1/GET2 | ER homeostasis, apoptosis | Overexpression and point mutation models |
GET complex in Cancer
Dysregulation of GET complex components has been implicated in cancer. For example, WRB (Get1) mutations or altered expression are associated with tumorigenesis, potentially through mislocalization of TA proteins involved in apoptosis and cell signaling. Targeting the GET complex may offer therapeutic opportunities in cancers dependent on TA protein biogenesis.
GET complex in Neurodegeneration
TA protein mislocalization due to GET complex dysfunction has been linked to neurodegenerative diseases. Impaired insertion of TA proteins such as syntaxins and Bcl-2 family members can disrupt neuronal vesicle trafficking and survival. Modulating GET complex activity may be a strategy to restore proteostasis in neurons.
GET complex in Parasitic Infections
The GET complex is essential for the viability of protozoan parasites, making it a validated drug target for diseases such as malaria and toxoplasmosis. Small-molecule inhibitors of the GET complex are being developed as antiparasitic agents.
From GET complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GET complex component affect TA protein insertion? | CRISPR knockout cell lines |
| Does a specific point mutation in Get3 affect ATPase activity? | Point mutation knock-in |
| Can a tagged Get3 be used to pull down TA proteins? | Tagged knock-in (e.g., GFP, HA) |
| Does overexpression of WRB rescue TA protein mislocalization? | Overexpression cell lines |
| Which genes regulate GET complex function? | CRISPR library screening |
| What is the interactome of the GET complex? | Bioinformatics and proteomics |
How to Study the GET complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| AP-MS | Protein-protein interactions | Identify GET complex interactors |
| BioID | Proximity-dependent biotinylation | Map spatial interactome |
| Fluorescence microscopy | Subcellular localization | Visualize GET complex dynamics |
| In vitro insertion assay | TA protein insertion into ER | Reconstitute GET complex function |
| ATPase assay | ATP hydrolysis by Get3 | Measure Get3 activity |
| CRISPR knockout screen | Gene essentiality and modifiers | Identify regulators of GET complex |
| RNA-seq | Transcriptional changes | Assess ER stress response |
| Bioinformatics | Genomic and transcriptomic data integration | Predict disease associations |
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify interactors of GET complex components. Proximity labeling approaches such as BioID can map the spatial interactome of the complex in living cells.
Imaging and Localization
Fluorescence microscopy of tagged GET complex subunits (e.g., GFP-Get3) allows visualization of their subcellular localization and dynamics. Super-resolution microscopy can resolve ER membrane insertion events.
Functional Assays
In vitro insertion assays using purified components can reconstitute TA protein insertion into ER-derived vesicles. ATPase activity assays measure Get3 function.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR knockout screens can identify genes that modulate GET complex function or TA protein biogenesis. Bioinformatics analysis of genomic and transcriptomic data can reveal regulatory networks and disease associations.
How CRISPR Can Be Used to Study GO:0043529 GET complex
Knockout
CRISPR knockout of GET complex genes (e.g., GET3, WRB, CAML) can abolish TA protein insertion, leading to mislocalization and cellular stress. Knockout cell lines are valuable for studying the essentiality of the complex and for identifying compensatory pathways.
Point Mutation
Point mutations in the ATPase domain of Get3 can be introduced using CRISPR to dissect the ATP hydrolysis cycle and its role in TA protein release. Such models help distinguish between binding and release defects.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) at endogenous loci allows for real-time tracking and affinity purification of GET complex components. Knock-in of disease-associated mutations can model human pathologies.
Overexpression
Overexpression of GET complex components can rescue loss-of-function phenotypes or amplify the pathway for biochemical studies. Inducible overexpression systems allow temporal control of GET complex activity.
How EDITGENE Supports GET complex Research
Researchers studying GET complex-related genes often need to determine whether a candidate gene is causally involved in TA protein biogenesis, ER homeostasis, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to interrogate GET complex biology with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for GET complex research.
Frequently Asked Questions About GET complex
What is the GET complex?
The GET complex is an endoplasmic reticulum protein complex that mediates the insertion of tail-anchored proteins into the ER membrane.
What genes are involved in the GET complex?
In yeast, the GET complex includes Get1p, Get2p, and Get3p; in metazoans, the orthologs are WRB, CAML, and TRC40/ASNA1.
What is the function of GO:0043529?
GO:0043529 is the Gene Ontology term for the GET complex, which functions in tail-anchored protein insertion into the ER membrane.
Where is the GET complex located?
The GET complex is located at the endoplasmic reticulum membrane.
Is the GET complex conserved?
Yes, the GET complex is conserved across eukaryotes.
What diseases are associated with the GET complex?
Dysfunction of the GET complex has been linked to cancer, neurodegeneration, and parasitic infections.
How can I study the GET complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to interrogate GET complex gene function.
What is the role of Get3 in the GET complex?
Get3 is a cytosolic ATPase that binds tail-anchored proteins and delivers them to the ER membrane.
What are tail-anchored proteins?
Tail-anchored proteins are a class of membrane proteins with a single C-terminal transmembrane domain that are inserted into the ER membrane by the GET complex.
Can EDITGENE help with GET complex research?
Yes, EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for GET complex studies.
Conclusion
The GET complex (GO:0043529) is a conserved ER protein complex essential for the post-translational insertion of tail-anchored proteins into the ER membrane. Its dysfunction is linked to cancer, neurodegeneration, and parasitic infections, making it a compelling target for basic and translational research. CRISPR-based models and high-throughput screening offer powerful tools to dissect its mechanism and identify therapeutic opportunities. EDITGENE provides end-to-end CRISPR services to accelerate GET complex research, from knockout and point mutation models to library screening and bioinformatics.
References
- 4. Meldal BHM et al.. 2022. Complex Portal 2022: new curation frontiers.. Nucleic Acids Res 50(D1):D578-D586 PMID: 34718729
